Three cases of neuromyelitis optica spectrum disorder

被引:1
|
作者
Matsusue, Eiji [1 ]
Fujihara, Yoshio [1 ]
Suto, Yutaka [2 ]
Takahashi, Shotaro [2 ]
Tanaka, Kenichiro [2 ]
Nakayasu, Hiroyuki [2 ]
Nakamura, Kazuhiko [1 ]
Ogawa, Toshihide [3 ]
机构
[1] Tottori Prefectural Cent Hosp, Dept Radiol, 730 Ezu, Tottori, Tottori 6800901, Japan
[2] Tottori Prefectural Cent Hosp, Dept Neurol, Tottori, Tottori 6800901, Japan
[3] Tottori Univ, Div Radiol, Dept Pathophysiol Therapeut Sci, Tottori 680, Japan
来源
ACTA RADIOLOGICA OPEN | 2016年 / 5卷 / 05期
关键词
Neuromyelitis optica spectrum disorder; aquaporin-4 (AQP4); white matter lesions; extensive transverse myelitis; vasogenic edema; apparent diffusion coefficient;
D O I
10.1177/2058460116641456
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Neuromyelitis optica (NMO) is characterized by attacks of optic neuritis and longitudinally extensive transverse myelitis. Cases positive for aquaporin 4 antibodies are classified to NMO spectrum disorder (NMOSD) which includes cases with optic neuritis, transverse myelitis, or with brain lesions typical of NMO. Our three cases with NMO/NMOSD revealed five imaging features: (i) extensive transverse cord lesions, extending more than three vertebral segments, partially persisting as cavitation; (ii) periependymal lesions; (iii) lesions of the corticospinal tracts; (iv) extensive and confluent hemispheric white matter lesions reflecting vasogenic edema and partially involving the cerebral cortices and basal ganglia; and (v) two patterns of serial hemispheric white matter lesions: one is cavitation and another is partial regression or disappearance. Cavitations, in the upper spinal cord and hemispheric white matter, are considered to be caused by severe vasogenic edema and are likely to be one of the characteristic findings in NMOSD.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Hemifacial anhidrosis in neuromyelitis optica spectrum disorder
    Miyaue, Noriyuki
    Yabe, Hayato
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2020, 8 (02): : 107 - 108
  • [32] Choroid Plexitis in Neuromyelitis Optica Spectrum Disorder
    Oh, Y. J.
    Lim, Y. M.
    Lee, E. J.
    Kim, H. J.
    Kim, K. K.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (03) : 380 - 381
  • [33] Neuromyelitis Optica Spectrum Disorder: A Case Report
    Yaregal, Samson
    Bekele, Nebiyu
    Gebrewold, Yonathan
    Tadesse, Abilo
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2021, 14 : 643 - 648
  • [34] Membranous nephropathy with Neuromyelitis optica spectrum disorder
    Li, Xiangling
    Wang, YanQiang
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 15 : 49 - 51
  • [35] Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
    Yamamura, Takashi
    Kleiter, Ingo
    Fujihara, Kazuo
    Palace, Jacqueline
    Greenberg, Benjamin
    Zakrzewska-Pniewska, Beata
    Patti, Francesco
    Tsai, Ching-Piao
    Saiz, Albert
    Yamazaki, Hayato
    Kawata, Yuichi
    Wright, Padraig
    De Seze, Jerome
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (22): : 2114 - 2124
  • [36] Controversies in the management of neuromyelitis optica spectrum disorder
    Bruscolini, Alice
    La Cava, Maurizio
    Mallone, Fabiana
    Marcelli, Michela
    Ralli, Massimo
    Sagnelli, Paolo
    Greco, Antonio
    Lambiase, Alessandro
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (11) : 1127 - 1133
  • [37] Frequency of comorbidities in neuromyelitis optica spectrum disorder
    Barzegar, M.
    Mirmosayyeb, O.
    Nehzat, N.
    Vaheb, S.
    Shaygannejad, V.
    Asgari, N.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 460 - 460
  • [38] Depression in patients with neuromyelitis optica spectrum disorder
    Seok, J. M.
    Choi, M.
    Kim, Y. S.
    Cho, E. B.
    Lee, H. L.
    Kang, S. -Y.
    Lee, K. H.
    Kim, B. J.
    Min, J. -H.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 94 - 94
  • [39] Choreoathetosis in a patient with neuromyelitis optica spectrum disorder
    Sugeno, Naoto
    Izumi, Rumiko
    Kato, Kazuhiro
    Nakashima, Ichiro
    Takeda, Atsushi
    Aoki, Masashi
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2013, 1 (04): : 154 - 156
  • [40] Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder
    Nie, Tina
    Blair, Hannah A.
    CNS DRUGS, 2022, 36 (10) : 1133 - 1141